0001104659-22-127961.txt : 20221216
0001104659-22-127961.hdr.sgml : 20221216
20221216175916
ACCESSION NUMBER: 0001104659-22-127961
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221214
FILED AS OF DATE: 20221216
DATE AS OF CHANGE: 20221216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL JOSEPH
CENTRAL INDEX KEY: 0001392297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40344
FILM NUMBER: 221469148
MAIL ADDRESS:
STREET 1: 5 DICARLO ROAD
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akoya Biosciences, Inc.
CENTRAL INDEX KEY: 0001711933
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 475586242
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE
STREET 2: 6TH FLOOR
CITY: MARLBOROUGH
STATE: MA
ZIP: 01762
BUSINESS PHONE: 855.896.8401
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE
STREET 2: 6TH FLOOR
CITY: MARLBOROUGH
STATE: MA
ZIP: 01762
4
1
tm2232955-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-12-14
0
0001711933
Akoya Biosciences, Inc.
AKYA
0001392297
DRISCOLL JOSEPH
100 CAMPUS DRIVE,6TH FLOOR
MARLBOROUGH
MA
01762
0
1
0
0
Chief Financial Officer
Common Stock
2022-12-14
4
M
0
10039
0.44
A
22539
D
Common Stock
2022-12-14
4
S
0
10039
12.6693
D
12500
D
Common Stock
2022-12-14
4
M
0
14574
0.44
A
27074
D
Common Stock
2022-12-14
4
S
0
14574
12.4550
D
12500
D
Employee Stock Option (Right to Buy)
0.44
2022-12-14
4
M
0
10039
0.00
D
2029-05-02
Common Stock
10039
123466
D
Employee Stock Option (Right to Buy
0.44
2022-12-14
4
M
0
14574
0.00
D
2029-05-02
Common Stock
14574
108712
D
Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.60 - $12.80. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.
Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.40 - $12.615. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.
Such performance-based option shares were issued in 2019. In 2020, the options vested as performance conditions were determined to have been achieved.
/s/ Joseph Driscoll, by Brian McKelligon, as Attorney-in-Fact
2022-12-16